<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110627</url>
  </required_header>
  <id_info>
    <org_study_id>Dx01</org_study_id>
    <nct_id>NCT03110627</nct_id>
  </id_info>
  <brief_title>Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead</brief_title>
  <acronym>Dx-AF</acronym>
  <official_title>Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Applied Health Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biotronik Canada Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Unity Health Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on&#xD;
      the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard&#xD;
      indications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recipients of implantable defibrillators (ICD) are at high risk of developing both AF and&#xD;
      stroke, given the presence of multiple cardiovascular risk factors. Oral anticoagulation can&#xD;
      prevent most strokes in patients with AF; provided that AF is recognized before a stroke&#xD;
      occurs. Up to about 40% of incident AF may be sub-clinical, producing minimal or no symptoms,&#xD;
      or being too short to allow detection.&#xD;
&#xD;
      DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified&#xD;
      on clinical grounds for a single-chamber ICD will be randomized to a VDD ICD (experimental&#xD;
      group) or single chamber ICD (control group).&#xD;
&#xD;
      The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the&#xD;
      ability to diagnose silent AF in patients without prior AF receiving an ICD for standard&#xD;
      indications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 31, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>DX AF is a prospective, randomized-controlled, open-label trial. Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation or atrial flutter lasting at least 6 minutes</measure>
    <time_frame>During the entire time of follow up - 3 years</time_frame>
    <description>Atrial Fibrillation or atrial flutter lasting at least 6 minutes detected by the ICD, ECG, Holter monitor or telemetry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for any ICD lead repositioning or replacement</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumothorax</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New pericardial effusion</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac tamponade</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure-related death or wound infection</measure>
    <time_frame>60 days</time_frame>
    <description>Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">188</enrollment>
  <condition>Cardiac Arrhythmias</condition>
  <condition>Atrial Fibrillation and Flutter</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Implantable Cardioverter-Defibrillators</condition>
  <arm_group>
    <arm_group_label>VDD ICD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VDD ICD - A single-lead ICD system with the ability to sense atrial rhythm from the floating electrode (a VDD-ICD known as the DX) - Experimental group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VVI ICD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VVI ICD - Single chamber ICD system - Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VDD ICD (experimental group)</intervention_name>
    <description>Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).&#xD;
The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.</description>
    <arm_group_label>VDD ICD</arm_group_label>
    <other_name>Experimental: DX ICD (experimental group)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single chamber VVI ICD (control group)</intervention_name>
    <description>Patients who are identified on clinical grounds for a single-chamber ICD will randomized to a VDD ICD (experimental group) or single chamber ICD (control group).&#xD;
The study will compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.</description>
    <arm_group_label>VVI ICD</arm_group_label>
    <other_name>Control: Single chamber VVI ICD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with ischemic or non-ischemic cardiomyopathy,&#xD;
&#xD;
          -  LVEF&lt;50%, scheduled for primary or secondary prevention ICD&#xD;
&#xD;
          -  Treating physicians feel that the use of single chamber ICD is appropriate&#xD;
&#xD;
          -  No ECG-documented history of AF or flutter&#xD;
&#xD;
          -  Age &gt; 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known AF or flutter&#xD;
&#xD;
          -  Current use of class I or III anti-arrhythmic medications&#xD;
&#xD;
          -  Participants unwilling to attend study follow-up visits, considered unreliable for&#xD;
             compliance or with an anticipated life expectancy less than 3 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene Crystal, MD, FRCP(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver Island Health Authority</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V8R 1J8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospital</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Sciences North</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scarborough and Rouge Hospital - Centenary Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M1E 4B9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IUCPQ - Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HSCM - L'Hôpital du Sacré-Coeur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUS - Centre Hospitalier Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Single-chamber ICD (implantable cardioverter-defibrillator)</keyword>
  <keyword>Cardiac Arrhythmias</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Atrial flutter</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

